Alaunos Therapeutics, Inc. (TCRT)

NASDAQ: TCRT · IEX Real-Time Price · USD

0.630

-0.021 (-3.21%)

At close: Jul 2, 2024, 4:00 PM

0.657

+0.027 (4.30%)

After-hours: Jul 2, 2024, 6:22 PM EDT

Alaunos Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2004
Net Income	-35.14	-37.73	-78.75	-79.98	-117.8	Upgrade
Depreciation & Amortization	2.6	3.25	2.25	1.13	0.63	Upgrade
Share-Based Compensation	2.8	3.53	10.77	6.83	7.34	Upgrade
Other Operating Activities	-0.4	1.73	4.26	15.01	68.97	Upgrade
Operating Cash Flow	-30.14	-29.23	-61.47	-57.01	-40.85	Upgrade
Capital Expenditures	1.35	-0.19	-3.32	-9.78	-0.28	Upgrade
Investing Cash Flow	1.35	-0.19	-3.32	-9.78	-0.28	Upgrade
Share Issuance / Repurchase	0.09	14.7	1.04	102.12	59.15	Upgrade
Debt Issued / Paid	-18.23	-8.33	24.74	0	0	Upgrade
Financing Cash Flow	-18.14	6.37	25.78	102.12	59.15	Upgrade
Net Cash Flow	-46.93	-23.06	-39.02	35.33	18.01	Upgrade
Free Cash Flow	-28.8	-29.43	-64.79	-66.79	-41.14	Upgrade
Free Cash Flow Margin	-575920.00%	-1007.02%	-16279.15%	-	-	Upgrade
Free Cash Flow Per Share	-1.80	-2.03	-4.53	-4.78	-3.67	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).